Prime Medicine Emerges with $315 Million to Develop Next Generation Gene Editing Platform
‘The Sky is [Not] Falling,’ Federal Circuit Urges as it Continues to Dismantle Broad Pharmaceutical Patents
A Framework for Protecting Your Invention Outside the U.S.
Patent Term Extension Introduced by the Fourth Amendment to the Chinese Patent Law
Growing Competition for the World’s Most Profitable Drug as Multiple New Adalimumab Biosimilars Launch
When Do My Patents Expire?
7th Circuit Hears Oral Arguments in Humira “Patent Thicket” Antitrust Case
Considerations for Protecting your Invention with Provisional Patent Applications
